BioSpace News Archive

Business

Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, reported business highlights and financial results for the third quarter ended September 30, 2021.

November 2, 2021
·
22 min read
Business

IDEXX Laboratories Announces Third Quarter 2021 Results

IDEXX Laboratories, Inc., a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced third quarter results, as well as an update on U.S. companion animal diagnostics trends.

November 2, 2021
·
35 min read
Business

PFIZER REPORTS THIRD-QUARTER 2021 RESULTS

Pfizer Inc. reported financial results for third-quarter 2021 and raised 2021 guidance(4) for revenues and Adjusted diluted EPS(3)

November 2, 2021
·
59 min read
Business

Premier, Inc. Reports Fiscal-Year 2022 First-Quarter Results

Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year 2022 first quarter ended September 30, 2021.

November 2, 2021
·
30 min read
Business

Matinas BioPharma to Webcast Conference Call Discussing Third Quarter 2021 Financial and Operational Results on November 8, 2021

Matinas BioPharma Holdings, Inc. today announced that the Company will host a conference call and live audio webcast on Monday, November 8, 2021 at 8:30 a.m. ET to discuss operational and financial results for the third quarter ended September.

November 2, 2021
·
5 min read
Business

Rhythm Pharmaceuticals Reports Third Quarter 2021 Financial Results

Rhythm Pharmaceuticals, Inc. today reported financial results and provided a business update for the third quarter ended September 30, 2021.

November 2, 2021
·
22 min read
Genetown

Surface Oncology to Present Preclinical Data for Lead Clinical Programs at the Society for Immunotherapy of Cancer 2021 Annual Meeting

Surface Oncology today announced that scientific posters sharing preclinical data will be presented at the Society for Immunotherapy of Cancer (SITC) 2021 Annual Meeting, to be held virtually and at the Walter E. Washington Convention Center in Washington, D.C. November 10-14, 2021.

November 2, 2021
·
6 min read
LAVA Therapeutics Announces Participation at Upcoming Scientific Conferences

LAVA Therapeutics N.V. today announced that Paul W.H.I. Parren, Ph.D. , executive vice president, head of research and development (R&D) at LAVA, will participate in three upcoming scientific conferences in November.

November 2, 2021
·
4 min read
Business

Aclaris Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update

Aclaris Therapeutics, Inc. today announced its financial results for the third quarter of 2021 and provided a corporate update.

November 2, 2021
·
10 min read
Business

Avanos Medical, Inc. Announces Third Quarter 2021 Results

Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2021 financial results.

November 2, 2021
·
17 min read